A new antibiotic has been approved to treat urinary tract infections by the Food and Drug Administration for the first time ...
Certain changes in vaginal discharge, seen by its colour and texture, can sometimes indicate infections, sexually transmitted ...
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
Blujepa is the first in a new class of oral antibiotics in 30 years. It is expected to launch in the second half of 2025 in the United States.
The Cleveland Clinic warns that hot tubs, even those that are treated, can be hot spots for bacteria and parasites.) People claiming to be former employees also jumped into the fray. Justine Smith, ...
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
FDA approves new UTI antibiotic that may help patients with recurring infections - A commercial launch of the antibiotic in ...
The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates of microbial resistance rise.
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.
8h
The FDA approved GSK's Blujepa for uncomplicated UTIs in female adults and pediatric patients, with phase 3 trials showing strong efficacy vs. nitrofurantoin.
The FDA has approved GSK’s gepotidacin, the first antibiotic for uncomplicated urinary tract infections in 30 years. The drug has been approved for female adults and adolescents with UTIs caused by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback